Lumexa Imaging (NASDAQ:LMRI) Shares Gap Up Following Analyst Upgrade

Shares of Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) gapped up prior to trading on Monday after Raymond James Financial upgraded the stock from an outperform rating to a strong-buy rating. The stock had previously closed at $10.80, but opened at $11.72. Raymond James Financial now has a $23.00 price target on the stock. Lumexa Imaging shares last traded at $11.63, with a volume of 116,667 shares traded.

Institutional Investors Weigh In On Lumexa Imaging

Several large investors have recently made changes to their positions in the business. Assetmark Inc. bought a new position in Lumexa Imaging during the fourth quarter valued at about $36,000. TD Asset Management Inc bought a new position in shares of Lumexa Imaging during the 4th quarter valued at approximately $1,264,000. Geode Capital Management LLC purchased a new stake in shares of Lumexa Imaging during the 4th quarter worth approximately $1,548,000. Seven Grand Managers LLC bought a new stake in shares of Lumexa Imaging in the 4th quarter worth approximately $11,942,000. Finally, Goldman Sachs Group Inc. purchased a new position in Lumexa Imaging in the fourth quarter valued at approximately $18,870,000.

Lumexa Imaging Trading Up 21.3%

About Lumexa Imaging

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).